The novel CXCR4 antagonist KRH-3955 is an orally bioavailable and extremely potent inhibitor of human immunodeficiency virus type 1 infection: comparative studies with AMD3100. (Q37247686)
Jump to navigation
Jump to search
scientific article published on 18 May 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The novel CXCR4 antagonist KRH-3955 is an orally bioavailable and extremely potent inhibitor of human immunodeficiency virus type 1 infection: comparative studies with AMD3100. |
scientific article published on 18 May 2009 |
Statements
1 reference
The novel CXCR4 antagonist KRH-3955 is an orally bioavailable and extremely potent inhibitor of human immunodeficiency virus type 1 infection: comparative studies with AMD3100. (English)
1 reference
Jonathan Toma
1 reference
Naoki Yamamoto
1 reference
Tsutomu Murakami
1 reference
Sei Kumakura
1 reference
Toru Yamazaki
1 reference
Reiko Tanaka
1 reference
Makiko Hamatake
1 reference
Kazu Okuma
1 reference
Wei Huang
1 reference
Jun Komano
1 reference
Mikiro Yanaka
1 reference
Yuetsu Tanaka
1 reference
1 reference
Identifiers
1 reference